E. Conner

发表

Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface

Andrew Leaver-Fay, Brian Kuhlman, Steven M Lewis, 2014, Nature Biotechnology.

Schiff base complexes of copper and zinc as potential anti-colitic compounds

E. Conner, W. Smith, J. Reglinski, 2017, BioMetals.

Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression.

J. Davis, J. Davis, E. Conner, 1996, Inflammatory bowel diseases.

Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain.

E. Nisenbaum, E. Conner, D. Leung, 2014, Osteoarthritis and cartilage.

Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis.

P. Elliott, J. Davis, J. Davis, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics

Jack B. Maguire, B. Kuhlman, Xiufeng Wu, 2020, Nature Communications.

Effects of cyclosporine or FK506 in chronic colitis.

E. Conner, M. Grisham, S. Aiko, 1997, The Journal of pharmacology and experimental therapeutics.

Cytokine and Nitric Oxide Production in the Acute Phase of Bacterial Cell Wall-Induced Arthritis

J. Davis, E. Conner, M. Grisham, 1997, Inflammation.

Oxidant-regulation of gene expression in the chronically inflamed intestine.

E. Conner, M. Grisham, I. Kurose, 1997, The Keio journal of medicine.

Selective proteasome inhibitors as anti-inflammatory agents.

E. Conner, M. Grisham, A. Cockrell, 1999, Expert opinion on investigational drugs.

Duration of the hemodynamic effects of N(G)-nitro-L-arginine methyl ester in vivo.

E. Conner, M. Grisham, L. Gray, 2000, Nitric oxide : biology and chemistry.

Reactive Oxygen Metabolites

E. Conner, A. Miles, S. Aiko, 1995, Clinical Immunotherapeutics.

S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis.

E. Conner, C. Yuan, B. Teegarden, 2001, The Journal of pharmacology and experimental therapeutics.

Cytokine and adhesion molecule expression in SCID mice reconstituted with CD4+ T cells.

D. Granger, S. Kawachi, E. Conner, 2000 .

Cytokine and Adhesion Molecule Expression in SCID Mice Reconstituted with CD4+ T Cells

S. Kawachi, E. Conner, R. Chervenak, 2000, Inflammatory bowel diseases.

Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis.

J. Davis, J. Davis, E. Conner, 1997, The Journal of pharmacology and experimental therapeutics.

Inflammation, free radicals, and antioxidants.

E. Conner, M. Grisham, Matthew B. Grisham, 1996, Nutrition.

E-Selectin expression in a murine model of chronic colitis.

S. Kawachi, E. Conner, M. Grisham, 2000, Biochemical and biophysical research communications.

Oxidants, transcription factors, and intestinal inflammation.

E. Conner, M. Grisham, D. Jourd’heuil, 1997, Journal of clinical gastroenterology.

GSK3 is a metabolic checkpoint regulator in B cells

J. Woodgett, A. Richardson, Julia Jellusova, 2016, Nature Immunology.

Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome.

P. Elliott, E. Conner, V. Palombella, 1999, Methods in enzymology.

Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics

Jack B. Maguire, B. Kuhlman, Xiufeng Wu, 2020, Nature Communications.

Serum proprotein convertase subtilisin kexin type 9 is correlated directly with serum LDL cholesterol.

Y. Qian, E. Conner, W. Alborn, 2007, Clinical chemistry.

Nitric Oxide: Biochemistry, Physiology, and Pathophysiology

E. Conner, M. Grisham, 1995 .

Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds

R. Betts, E. Conner, J. Oleske, 1987, Antimicrobial Agents and Chemotherapy.

Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodies

Dongmei He, Xiufeng Wu, A. Sereno, 2015, mAbs.

Generation and Activity of a Humanized Monoclonal Antibody That Selectively Neutralizes the Epidermal Growth Factor Receptor Ligands Transforming Growth Factor-α and Epiregulin

S. Harlan, M. Breyer, A. Datta-Mannan, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Generation and Activity of a Humanized Monoclonal Antibody that Selectively Neutralizes the Epidermal Growth Factor Receptor Ligands TGF-alpha and Epiregulin

M. Breyer, A. Datta-Mannan, E. Conner, 2014 .

Comparing domain interactions within antibody Fabs with kappa and lambda light chains

M. Dickey, Xiufeng Wu, F. Huang, 2016, mAbs.

Genetically engineered models of inflammatory bowel disease

E. Conner, M. Grisham, S. Aiko, 1994 .

Oxygen Radicals and Tissue Injury

E. Conner, M. Grisham, D. Blake, 2014, Inflammation Research.